L110F (p.Leu110Phe) variant of IRS1 (Insulin receptor substrate 1)
L110F (p.Leu110Phe) in IRS1 (Insulin receptor substrate 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
L110F (p.Leu110Phe) variant details
- p.Leu110Phe
- NCI-TCGA Cosmic COSV1005
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.